Pharmaceutical distributors Cardinal Health Inc. and AmerisourceBergen Corp. this week announced the election of new board members. Cardinal said that Nancy Killefer is slated to join its board as an independent director on Sept. 14. Most recently, she was senior partner of McKinsey & Co.
Next week, Mylan N.V. plans to make a formal offer directly to the shareholders of Perrigo plc to buy the company. Mylan said Tuesday that it aims to make the bid on Monday, Sept. 14. Under the offer, Perrigo shareholders would receive $75 in cash and 2.3 Mylan ordinary shares for each
After a seven-year absence, Hydrox sandwich cookies are being relaunched by Leaf Brands LLC. Leaf Brands kicked off the relaunch on Friday at its production facility in Vernon, Calif.
NeutriSci International Inc. has entered a national distribution agreement for its NeuEnergy chewable energy tablets with Rite Aid Corp., which has nearly 4,600 drug stores in 31 states and the District of Columbia.
Health care software, analytics and payment service provider Emdeon plans to rename as Change Healthcare to better reflect its diverse capabilities and solutions. The company said late Thursday that the rebranding is slated to begin in the fourth quarter of this year.
Sandoz has inaugurated a new era in medicine with the release of Zarxio, the first biosimilar of a biologic drug approved in the United States. The Novartis subsidiary said Thursday that Zarxio — a biosimilar of Amgen Corp.
Par Pharmaceutical has released testosterone gel 1%, a generic version of AndroGel 1% from AbbVie. Par said Wednesday that its testosterone gel 1% product is available in 2.5g and 5g aluminum foil packets containing 25 mg or 50 mg of testosterone, respectively.
Lannett Co. plans to acquire Kremers Urban Pharmaceuticals Inc., the U.S. specialty generic drug subsidiary of UCB S.A., in a $1.23 billion deal. Lannett said late Wednesday that the acquisition will add a diversified commercial product portfolio of 18 products.
Hershey Co. has made its Ice Breakers mints available via the Amazon Dash Button, a miniature device that makes it easier for consumers to reorder their favorite products.
Sandoz has launched a rivastigmine patch, a treatment for dementia, in the U.S. market. The Novartis subsidiary said Wednesday that its rivastigmine transdermal system is an authorized generic version of the Exelon patch, marketed by Novartis Pharmaceuticals Corp.
Sundial Brands, the maker of natural beauty care brands SheaMoisture and Nubian Heritage, has sold a minority interest in the company to global investment firm Bain Capital Private Equity.
J M Smith Corp. has acquired pharmacy-related technology products and services offered by Integra NV and will manage them as a subsidiary called Integra LTC Solutions LLC.
Sanofi and the life sciences team at Google have formed a collaboration to improve care and outcomes for people with type 1 and type 2 diabetes.
NeilMed Pharmaceuticals Inc. USA has rolled out the Naspira nasal-oral aspirator for babies and small children.
Perrigo Co. plc has acquired the ScarAway scar management brand from Enaltus LLC. Financial terms of the transaction weren’t disclosed. Perrigo said Monday that Scaraway is expected to generate overall 2015 net sales of $10 million, or approximately $3 million for the remainder of the year.
Early feedback on the Food and Drug Administration’s proposal on naming conventions for biosimilars shows a mixed response.
